Trial intelligence / Profile preview

SNAP: Steroids and/or NSAIDs After Trabeculectomy

2024-511820-15-03Phase 4Completed

Sponsor
Rigshospitalet
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of diclofenac and lisinopril + hydrochlorothiazide in open-angle glaucoma (OAG), pseudoexfoliation glaucoma (PXG), pigmentary glaucoma (PG) and 1 more (3 arms), sponsored by Rigshospitalet. Primary endpoint: Intraocular pressure at 12 months. Started Nov 2024; status: completed.

02

Drugs

diclofenaclisinopril + hydrochlorothiazide
03

Conditions

open-angle glaucoma (OAG)pseudoexfoliation glaucoma (PXG)pigmentary glaucoma (PG)ocular hypertension

Beyond the preview

Go deeper on 2024-511820-15-03.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-511820-15-03.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call